http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20110097956-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1a492249f7c578d2de84acf52e0be26a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_78d4470ccfa7e1f4fd24a95c2f852ae3
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7034
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
filingDate 2009-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d2e734a698dfd255156a86e84420b431
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_631234f49e17ccaf96c405059d3b3b39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d47f890bdcf8755008769ea4e07bde3e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9b980f9342656feef2949dc745c907c1
publicationDate 2011-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-20110097956-A
titleOfInvention Decay
abstract The present invention provides a tablet comprising a hygroscopic drug and having excellent disintegration, strength and drug stability. Specifically, the present invention provides a drug having an equilibrium moisture content of 10 to 20% under 75% relative humidity at 25 ° C, erythritol, mannitol, and an equilibrium moisture content of 5% under 75% relative humidity at 25 ° C. 20%, a disintegrating tablet containing hydroxypropyl cellulose having a viscosity of 100 to 2000 cps at 37 ° C in a 20% by mass aqueous solution, wherein the disintegrating tablet contains 15 to 50% by mass of the drug relative to the total amount of the disintegrating tablet. And disintegrating tablets having a porosity of 10 to 40%.
priorityDate 2008-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527835
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23665634
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559553
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419591227
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5360545
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415967960
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID56841934
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID445421
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID222285
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6917
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419530273
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454299274
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID151263
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419482110
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452788844
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID169019
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397383
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559505
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10239
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5460341
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6251
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534805
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415853316

Total number of triples: 48.